Literature DB >> 8286518

The influence of splenectomy on infective morbidity after colonic and splenic injuries.

W K Huizinga1, L W Baker.   

Abstract

OBJECTIVE: To establish the incidence of early postoperative infections after civilian injuries to the spleen, colon, or both and assess the effect of splenectomy on outcome.
DESIGN: Retrospective study of case notes.
SETTING: University hospital.
SUBJECTS: 403 Patients of whom 353 had splenic injuries, 91 with associated colonic injuries, together with 50 randomly selected patients with colonic injuries alone. MAIN OUTCOME MEASURES: Morbidity and mortality.
RESULTS: 45 Patients had splenectomy and colonic injury (group 1), 46 had a colonic injury and the spleen conserved (group 2) 50 had colonic injury alone (group 3), 143 had splenectomy for injured spleen without colonic injury (group 4), and 119 had the spleen injured and conserved without colonic injury (group 5). Their mean age was 28 years. Overall mean Injury Severity Score (ISS) was 30.1, and Abdominal Trauma Index (ATI) 22.4. 68/403 died (17%), more than half within 48 hours. Early mortality was higher in both groups in which the spleen was removed but after stratification by ISS and ATI the differences were not significant. Late mortality (after 48 hours) associated with sepsis did not differ significantly among the groups, nor did the rate of infective complications. Mechanism and severity of injury had the most influence on morbidity and mortality.
CONCLUSION: Removal of an injured spleen does not have an adverse influence on the incidence of serious infective complications in the early postoperative period in patients with injuries to the spleen, the colon, or both.

Entities:  

Mesh:

Year:  1993        PMID: 8286518

Source DB:  PubMed          Journal:  Eur J Surg        ISSN: 1102-4151


  1 in total

1.  A solution to the negative effects of splenectomy during colorectal trauma and surgery: an experimental study on splenic autotransplantation to the groin area.

Authors:  Bora Karip; Metin Mestan; Özgen Işık; Metin Keskin; Kafkas Çelik; Yalın İşcan; Kemal Memişoğlu
Journal:  BMC Surg       Date:  2015-12-18       Impact factor: 2.102

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.